RIRodrigo Cabello Ibacache

Rodrigo Cabello Ibacache

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rodrigo Cabello Ibacache has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteolytic enzymes in dentin erosion: roles of matrix metalloproteinases and cathepsins and the effectiveness of synthetic and natural inhibitors—a systematic review

    by Valeria C. Gómez, Alain Chaple Gil, Mario Diaz-Dosque, Rodrigo Cabello Ibacache, Eduardo Fernández Godoy

    To evaluate the role of matrix metalloproteinases (MMPs) and cathepsins in dentin erosion and assess the efficacy of synthetic and natural inhibitors in preventing collagen matrix degradation and preserving dentin integrity. A systematic literature search was conducted and updated in January 2025 across PubMed, Scopus, and Web of Science, targeting studies that investigated the role of matrix metalloproteinases (MMPs) and/or cysteine cathepsins in dentin erosion or erosion-abrasion models. In vitro, in situ, and in vivo experimental studies evaluating the effects of synthetic and natural protease inhibitors were included. Study selection, data extraction, and risk of bias assessment were performed following PRISMA 2020 guidelines. A total of 22 studies met the inclusion criteria, comprising predominantly in vitro designs, alongside in situ and combined experimental models. Across studies, MMP-2, MMP-8, and MMP-9, together with cathepsin K, were consistently identified as key enzymes involved in collagen degradation following acidic challenges. Erosive protocols varied in pH, exposure time, and cycling frequency, but uniformly promoted demineralization and enzymatic activation. Synthetic inhibitors (e.g., ferrous sulfate, stannous fluoride) and natural compounds (e.g., green tea catechins, theaflavins) demonstrated significant reductions in enzymatic activity and dentin loss. Importantly, studies assessing combined inhibition of MMPs and cathepsins reported the greatest protective effects, supporting a multimodal strategy to limit erosive dentin degradation. Acidic challenges promote the activation of matrix metalloproteinases and cysteine cathepsins, thereby accelerating dentin erosion through progressive collagen degradation. Both synthetic and natural inhibitors were shown to attenuate proteolytic activity and reduce dentin loss under experimental conditions. Notably, strategies targeting multiple enzymatic pathways consistently demonstrated greater protective effects than single-agent approaches. Nevertheless, the predominance of in vitro and in situ evidence highlights the need for well-designed clinical studies to confirm the long-term efficacy and translational relevance of these interventions. The incorporation of MMP and cathepsin inhibitors into preventive and therapeutic oral care strategies represents a promising adjunct for enhancing dentin resistance to erosive challenges. However, clinical implementation requires standardized experimental protocols, clearer dose-response characterization, and validation in long-term clinical settings. Advancing dual-targeted inhibitory approaches may contribute to more effective and durable dentin preservation in patients at risk of erosive tooth wear.


  • A comprehensive evidence synthesis of anti-erosive dentifrices: An umbrella review of systematic reviews

    by Valeria C. Gómez, Mario Diaz-Dosque, Constanza E. Fernández, Cristian Bersezio, Rodrigo Cabello Ibacache, Eduardo Fernández Godoy


  • Probiotic supplementation and dental caries prevention in children and adolescents: a systematic review of strain-specific and context-dependent effects

    by Gonzalo Rodriguez, Eduardo Fernández Godoy, Alain Chaple Gil, Rafael Contador, Cristian Bersezio Miranda, Rodrigo Cabello

    Objectives This systematic review evaluates whether probiotic supplementation may provide adjunctive, strain-specific benefits in the prevention and modulation of dental caries outcomes in children and adolescents. The primary outcomes analyzed included caries incidence, lesion progression or regression (ICDAS, dmfs/DMFS), and microbiological parameters such as Streptococcus mutans and Lactobacillus counts. Materials and methods A comprehensive literature search was performed following PRISMA 2020 guidelines across PubMed, Scopus, Web of Science, Cochrane Library, and EMBASE. Randomized controlled trials comparing probiotic interventions with placebo or standard care were included. Two reviewers independently performed study selection, data extraction, and risk of bias assessment using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Randomized Controlled Trials. Due to considerable clinical and methodological heterogeneity among studies particularly in probiotic strain, dosage, delivery vehicle, and outcome measurement a narrative synthesis was undertaken in accordance with JBI guidance. Results Twelve randomized controlled trials met the inclusion criteria. Probiotic supplementation, particularly with Lactobacillus rhamnosus SP1 and L. paracasei SD1 administered via milk or tablets for 6–10 months, significantly reduced caries incidence and S. mutans counts compared with control groups. Evidence regarding the prevention of caries recurrence (secondary prevention) and the regression of white spot lesions in orthodontic patients was limited and inconsistent. The overall certainty of evidence, assessed using GRADE/ConQual, was moderate for primary prevention and low for secondary outcomes. Conclusions Probiotic supplementation may provide modest, strain-specific adjunctive benefits for caries prevention in high-risk pediatric populations; however, the certainty of evidence remains moderate to low, and findings are inconsistent across strains, delivery vehicles, and outcomes. Clinical relevance The findings support the biological plausibility of probiotics in caries management and suggest a potential adjunctive role within preventive dentistry strategies, particularly in selected high-risk populations.


  • Open Access

    Therapeutic Interventions to Manage Oral Mucositis and Their Impact on Quality of Life in Cancer Patients: An Umbrella Review

    by Joatan Lucas de Sousa Gomes Costa, Leonardo Díaz, Alain Chaple Gil, Gonzalo Rodríguez Martínez, Rodrigo Cabello Ibacache, Cristian Bersezio Miranda, Alfredo Von Marttens, Javier Basualdo, Eduardo Fernández Godoy, Milton Carlos Kuga

    Background: Oral mucositis (OM) is a debilitating complication of cancer therapy, particularly in head and neck cancer patients, with significant adverse effects on quality of life (QoL). Although numerous interventions have been investigated, their impact on QoL remains inconsistently reported and poorly synthesized. Methods: An umbrella review was conducted following PRISMA 2020 and Joanna Briggs Institute (JBI) guidelines. Five databases (PubMed, Embase, Scopus, Web of Science, and Cochrane Library) were searched from inception to March 2024. Reviews were eligible if they evaluated any therapeutic intervention for OM and reported QoL‐related outcomes using validated tools. Methodological quality was appraised using AMSTAR 2, and findings were narratively synthesized and thematically categorized. The protocol was registered in PROSPERO (CRD420251044088). Results: Eight systematic reviews (257 primary studies) met the inclusion criteria. Photobiomodulation, honey, black mulberry, and botanical agents such as SAMITAL showed consistent improvement in QoL domains, including pain relief, oral function, and emotional well‐being. Gabapentin demonstrated potential in reducing opioid use and early mucositis‐related pain, though findings were mixed across trials. QoL was most commonly assessed using the EORTC QLQ‐C30, FACT‐HN, and UW‐QOL. Overall, heterogeneity in intervention protocols and QoL instruments limited comparability. Conclusions: This review highlights the most promising interventions for improving QoL in patients with OM. Standardizing QoL measurement and prioritizing patient‐reported outcomes in future trials is essential to inform evidence‐based supportive oncology care.


  • Effect of probiotic supplementation on the progression of non‐cavitated carious lesions in children: A 12‐month randomized controlled trial

    by Rodrigo Cabello Ibacache, Simone Faleiros, Mario Díaz‐Dosque, Begoña Ruiz, Rafael Contador, Begoña Moreno, Eduardo F. Godoy, Gonzalo Rodríguez Martínez

    This double‐blind, placebo‐controlled, cluster‐randomized clinical trial evaluated the effectiveness of daily Lactobacillus rhamnosus SP1 supplementation in reducing caries progression in preschool children. A total of 205 children aged 2–3 years from 10 public nursery schools in Santiago, Chile, were randomized by nursery school clusters (1:1) to receive either probiotic‐supplemented milk (1 × 10 7 CFU/mL) or standard milk once daily for 10 months. Examinations were conducted at baseline and 12 months using ICDAS criteria. The primary outcome was the proportion of children whose caries status progressed to cavitated lesions (ICDAS 5–6). Progression occurred in 26.8% of children in the probiotic group (33/123) and 46.3% in the control group (38/82). Surface‐level transitions were minimal in both groups and are reported descriptively. No intervention‐related adverse events were observed, and adherence exceeded 80%. Daily consumption of milk supplemented with L. rhamnosus SP1 for 10 months reduced the number of preschool children who developed cavitated carious lesions over a 12‐month period and may represent a safe and feasible adjunct for community‐based prevention of early childhood caries. The trial was prospectively registered at ClinicalTrials.gov (NCT01648075).